315 related articles for article (PubMed ID: 33389269)
21. Formulation of Saxagliptin Oral Films: Optimization, Physicochemical Characterization, In-Vivo Assessment, and In-Vitro Real-Time Release Monitoring via a Novel Polyaniline Nanoparticles-Based Solid-Contact Screen Printed Ion-Selective Electrode.
Makram TS; Eid SM; Abu-Dahab M; AbouGhaly MHH; Elnahas OS
AAPS PharmSciTech; 2024 May; 25(5):116. PubMed ID: 38769223
[TBL] [Abstract][Full Text] [Related]
22. Understanding the Impact of Multi-factorial Composition on Efficient Loading of the Stable Ketoprofen Nanoparticles on Orodispersible Films Using Box-Behnken Design.
Shah HG; Rathod V; Basim P; Gajera B; Dave RH
J Pharm Sci; 2022 May; 111(5):1451-1462. PubMed ID: 34678275
[TBL] [Abstract][Full Text] [Related]
23. Formulation of Orally Disintegrating Films as an Amorphous Solid Solution of a Poorly Water-Soluble Drug.
Panraksa P; Tipduangta P; Jantanasakulwong K; Jantrawut P
Membranes (Basel); 2020 Nov; 10(12):. PubMed ID: 33261025
[TBL] [Abstract][Full Text] [Related]
24. Orodispersible films and tablets with prednisolone microparticles.
Brniak W; Maślak E; Jachowicz R
Eur J Pharm Sci; 2015 Jul; 75():81-90. PubMed ID: 25889975
[TBL] [Abstract][Full Text] [Related]
25. Comparison of Solvent Casting and Spray Casting Method on Compounding of an Orally Disintegrating Film Containing Amlodipine Besylate.
Ruslan MFH; Janakiraman AK; Ming LC; Uddin AH; Sarker ZI; Bin LK
Int J Pharm Compd; 2022; 26(2):155-162. PubMed ID: 35413014
[TBL] [Abstract][Full Text] [Related]
26. Development and characterization of pullulan-based orally disintegrating films containing amlodipine besylate.
Pezik E; Gulsun T; Sahin S; Vural İ
Eur J Pharm Sci; 2021 Jan; 156():105597. PubMed ID: 33065224
[TBL] [Abstract][Full Text] [Related]
27. Natural and semisynthetic polymers blended orodispersible films of citalopram.
Shahzad Y; Maqbool M; Hussain T; Yousaf AM; Khan IU; Mahmood T; Jamshaid M
Nat Prod Res; 2020 Jan; 34(1):16-25. PubMed ID: 30663358
[TBL] [Abstract][Full Text] [Related]
28. Influence of Polyvinyl Alcohol (PVA) on PVA-Poly-N-hydroxyethyl-aspartamide (PVA-PHEA) Microcrystalline Solid Dispersion Films.
Al-Sahaf Z; Raimi-Abraham B; Licciardi M; de Mohac LM
AAPS PharmSciTech; 2020 Oct; 21(7):267. PubMed ID: 33006710
[TBL] [Abstract][Full Text] [Related]
29. Formulation design, characterization and in vitro drug release study of orodispersible film comprising BCS class II drugs.
Sheikh FA; Aamir MN; Shah MA; Ali L; Anwer K; Javaid Z
Pak J Pharm Sci; 2020 Jan; 33(1(Supplementary)):343-353. PubMed ID: 32122867
[TBL] [Abstract][Full Text] [Related]
30. Development and Characterization of an Orodispersible Film for Vitamin D3 Supplementation.
Cupone IE; Dellera E; Marra F; Giori AM
Molecules; 2020 Dec; 25(24):. PubMed ID: 33322282
[TBL] [Abstract][Full Text] [Related]
31. Formulation Optimization and in Vitro Characterization of Orally Disintegrating Films Using a Factorial Design and Mathematical Modeling for Drug Release.
Lee Y; Thapa P; Jeong SH; Woo MH; Choi DH
Chem Pharm Bull (Tokyo); 2017 Feb; 65(2):166-177. PubMed ID: 27904030
[TBL] [Abstract][Full Text] [Related]
32. [Preparation and quality evaluation of orodispersible film containing ginkgolide B novel nanosuspension lyophilized powder].
Jing W; Jun-Jun Z; Bao-de S; Ting Z; Bo D; Ya-Ning Z; Hai-Long Y
Zhongguo Zhong Yao Za Zhi; 2020 Nov; 45(22):5504-5510. PubMed ID: 33350212
[TBL] [Abstract][Full Text] [Related]
33. Pharmaceutical and pharmacokinetic evaluation of a novel fast dissolving film formulation of flupentixol dihydrochloride.
Abdelbary A; Bendas ER; Ramadan AA; Mostafa DA
AAPS PharmSciTech; 2014 Dec; 15(6):1603-10. PubMed ID: 25142820
[TBL] [Abstract][Full Text] [Related]
34. Preparation and Evaluation of Caffeine Orodispersible Films: The Influence of Hydrotropic Substances and Film-Forming Agent Concentration on Film Properties.
Vlad RA; Pintea A; Coaicea M; Antonoaea P; Rédai EM; Todoran N; Ciurba A
Polymers (Basel); 2023 Apr; 15(9):. PubMed ID: 37177181
[TBL] [Abstract][Full Text] [Related]
35. Model-based description of disintegration time and dissolution rate of nanoparticle-loaded orodispersible films.
Steiner D; Finke JH; Kwade A
Eur J Pharm Sci; 2019 Apr; 132():18-26. PubMed ID: 30794870
[TBL] [Abstract][Full Text] [Related]
36. Fabrication and Characterization of Orodispersible Composite Film from Hydroxypropylmethyl Cellulose-Crosslinked Carboxymethyl Rice Starch.
Kittipongpatana OS; Trisopon K; Wattanaarsakit P; Kittipongpatana N
Membranes (Basel); 2022 Jun; 12(6):. PubMed ID: 35736301
[TBL] [Abstract][Full Text] [Related]
37. Effect of casting solvent, film-forming agent and solubilizer on orodispersible films of a polymorphic poorly soluble drug: an
El-Bary AA; Al Sharabi I; Haza'a BS
Drug Dev Ind Pharm; 2019 Nov; 45(11):1751-1769. PubMed ID: 31416366
[TBL] [Abstract][Full Text] [Related]
38. Characterization and optimization of orodispersible mosapride film formulations.
ElMeshad AN; El Hagrasy AS
AAPS PharmSciTech; 2011 Dec; 12(4):1384-92. PubMed ID: 22009305
[TBL] [Abstract][Full Text] [Related]
39. A Novel Technique to Improve Drug Loading Capacity of Fast/Extended Release Orally Dissolving Films with Potential for Paediatric and Geriatric Drug Delivery.
Ouda GI; Dahmash EZ; Alyami H; Iyire A
AAPS PharmSciTech; 2020 May; 21(4):126. PubMed ID: 32382992
[TBL] [Abstract][Full Text] [Related]
40. Semi-solid extrusion 3D printing ODFs: an individual drug delivery system for small scale pharmacy.
Yan TT; Lv ZF; Tian P; Lin MM; Lin W; Huang SY; Chen YZ
Drug Dev Ind Pharm; 2020 Apr; 46(4):531-538. PubMed ID: 32141352
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
